NIH's Role In Sustaining the U.S. Economy 2021 Update Now Available here
UMR Urges House and Senate Leaders to Include NIH Funding in COVID Relief Package read here
UMR releases new fact sheets on COVID-19 and biomedical research. Read here
See how UMR members are aiding in the fight against the coronavirus here
A new episode of the Amazing Things Podcast is now available! Check it out here.

A participant in the NIH 2019-2020 Medical Research Scholars Program.

Photo Credit: National Institutes of Health

About This Photo

Biomarkers Say COVID-19 Brain Damage Is Like Alzheimer’s, But Faster

Biomarkers Say COVID-19 Brain Damage Is Like Alzheimer’s, But Faster

The link between COVID-19 and the onset of dementia or even Alzheimer’s is not yet known — and researchers will need years more to understand any relationship there in full — but, evidence is growing that the diseases do share the biomarkers of brain damage. And according to a new study, COVID-19 appears to bring … Continued

COVID-19 May Damage the Brain in Older Adults

While COVID-19 is notorious for wreaking havoc on the body, new research shows it could also impact the brain. Studies presented at the Alzheimer’s Association International Conference® 2021 (AAIC®) in July found links between COVID-19 and persistent cognitive deficits, including the acceleration of Alzheimer’s-related brain changes and symptoms.

Depression Rates in US Tripled When the Pandemic First Hit—Now, They’re Even Worse

Depression among adults in the United States tripled in the early 2020 months of the global coronavirus pandemic—jumping from 8.5 percent before the pandemic to a staggering 27.8 percent. New research from Boston University School of Public Health reveals that the elevated rate of depression has persisted into 2021, and even worsened, climbing to 32.8 … Continued

Research suggests global dementia cases could triple by 2050, and also that COVID-19 accelerates Alzheimer’s

Research presented at the Alzheimer’s Association International Conference 2021 suggests COVID-19 is associated with long-term cognitive dysfunction and acceleration of Alzheimer’s disease pathology and symptoms. These studies were among several pieces of groundbreaking research featured at AAIC 2021.  

The Impact of COVID-19 and the Global Pandemic on Alzheimer’s Research, Long-Term Care and the Brain

COVID-19 and the global pandemic have caused significant disruption to all aspects of life including Alzheimer’s clinical research worldwide. The impact of COVID, quarantine, and the resulting fear and isolation are causing problems, but also driving unprecedented innovation. Yet the urgency to make scientific advances in Alzheimer’s and other dementia is so high that we … Continued

Five key findings emerge from Alzheimer’s Association Conference

Research presented at the recent Alzheimer’s Association International Conference (AAIC) 2021 suggests COVID-19 is associated with long-term cognitive dysfunction and acceleration of Alzheimer’s disease pathology and symptoms. These studies were among several pieces of groundbreaking research featured at AAIC. Nearly 12,000 attendees, both in-person and virtual, joined the conference – the world’s largest and most … Continued

COVID-19 Associated with Long-Term Cognitive Dysfunction, Acceleration of Alzheimer’s Symptoms

Much has been learned about SARS-CoV-2, the virus that causes the novel coronavirus, since the beginning of the COVID-19 pandemic. However, questions remain about the long-term impact of the virus on our bodies and brains. New research reported at the Alzheimer’s Association International Conference® (AAIC®) 2021, held virtually and in Denver found associations between COVID-19 … Continued

International Brain Study: SARS-CoV-2 Impact on Behavior and Cognition

Scientific leaders, including the Alzheimer’s Association and representatives from more than 25 countries — with technical guidance from the WHO — have formed an international, multidisciplinary consortium to collect and evaluate the short- and long-term consequences of the viral infection on the central nervous system (CNS), as well as the differences across countries on the … Continued

The Brain and Covid: Strides and Speculations

One year on, science has discovered much about the effects on the brain, but there is still much to learn.

The State of Alzheimer’s 2021: Stress, COVID-19, Disparities and Racism

The just-released annual state-of-the-disease report from the Alzheimer‘s Association, where Maria Carrillo is chief science officer, highlights how the past year’s crises reflect challenges for those touched by the disease. Based on two national surveys, it’s the “deepest dive ever done” by the association into racial and ethnic perspectives, Carrillo says. For the first time, Native … Continued